Skip to main content

ICLR · Icon PLC · Metrics

Track ICLR — free
$187.02 -3.35 (-1.76%) Play latest call Q3 2026 earnings call transcript
Market Cap
$13.78B
Shares
74.92M
Volume · Nov 20 367.76K Avg daily vol (3M) 977.37K

ICLR metrics

94 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$190.36
Market cap
$13.78B

Price action

23 metrics
Price change (1W)
-5.1%
Price change (30D)
+2.8%
Price change (3M)
+9.2%
Price change (6M)
+63.3%
Price change (YTD)
+4.5%
Price change (1Y)
+19.9%
Trailing year
Price change (5Y)
-33.5%
52-week high
$215.48
52-week low
$80.08
Change from 52-week high
-11.7%
Change from 52-week low
+137.7%
Annualized volatility
68.5%
Annualized volatility (3M)
49.9%
Implied volatility (30D)
46.8%
IV rank (1Y)
13.2
IV percentile (1Y)
20.6
Beta
1.2
RSI (14D)
48.0
Price vs SMA 50
+4.9%
Price vs SMA 200
+29.4%
Avg volume (3M)
977,369
Relative volume
1.0
Average dollar volume
$177.70M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
74.92M

Valuation

12 metrics
P / E (TTM)
32.3
Trailing earnings · reciprocal yield 3.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 59.8%
P / book
1.5
reciprocal yield 66.2%
FCF yield
6.2%
TTM · current market cap
Buyback yield
2.9%
P / FCF
16.1
reciprocal yield 6.2%
P / operating cash flow
13.4
reciprocal yield 7.5%
Earnings yield
3.3%

Historical valuation

8 metrics
P / E historical average (3Y)
49.9×
reciprocal yield 2.0%
P / E historical average (5Y)
52.7×
reciprocal yield 1.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
—
Operating margin
8.7%
Trailing 12 months
Net margin
5.4%
Gross profit (TTM)
$839.55M
Operating profit (TTM)
$718.25M
Net income (TTM)
$448.66M
Trailing 12 months
Diluted EPS (TTM)
$5.90
FCF margin
10.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$106.22
Gross profit per diluted share (TTM)
$15.80
Operating profit per diluted share (TTM)
$9.26
EBITDA per diluted share (TTM)
$13.98
Net income per diluted share (TTM)
$5.78
Operating cash flow per diluted share (TTM)
$13.26
Free cash flow per diluted share (TTM)
$11.06
Capital expenditures per diluted share (TTM)
$2.20
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.20
Book value per share
$121.83

Growth

11 metrics
Revenue growth YoY
-2.9%
Year over year
Net income growth YoY
-69.0%
Revenue (TTM)
$8.23B
Trailing 12 months
EPS growth YoY
-67.4%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+24.2%
EPS CAGR (3Y)
-22.1%
EPS CAGR (5Y)
-14.0%
FCF CAGR (3Y)
+27.0%
FCF CAGR (5Y)
+10.3%

Quality

14 metrics
Return on equity
4.9%
Return on assets
2.8%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
$1.08B
Free cash flow (TTM)
$857.06M
Quick ratio
—
Interest coverage
3.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$808.98M
Total assets
$16.24B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.03B
Capital expenditures (TTM)
$170.51M
R&D (TTM)
—
SG&A (TTM)
$771.47M
Stock compensation (TTM)
$92.83M
R&D / revenue
—
Stock compensation / revenue
1.1%

Ownership (13F)

9 metrics
13F filers
424
13F filer change QoQ
-1
Institutional ownership
101.8%
Conviction holders (share of 13F filers)
3.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-4.4%
Holder tenure
15.5
Price vs estimated holder cost
+6.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.3%

Short interest

3 metrics
Short interest
3.2%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.51M
Insider-sentiment score
10 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1060955 CUSIP G4705A100 13F (30d) 438 filings 393 filers Visit website Investor relations